CONTENTS:
- Congratulations on the 10-year anniversary of the National Drug Abuse Treatment Clinical Trial Network--now, what's new for the coming decade?, Mclellan A. T., p. S1-3.
- The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment, Tai B., Straus M. M., Liu D., Sparenborg S., Jackson R., Mccarty D., p. S4-13.
- Study results from the Clinical Trials Network's first 10 years: where do they lead?, Wells E. A., Saxon A. J., Calsyn D. A., Jackson T. R., Donovan D. M., p. S14-30.
- Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network, Martino S., Brigham G. S., Higgins C., Gallon S., Freese T. E., Albright L. M., et al., p. S31-43.
- A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network, Roman P. M., Abraham A. J., Rothrauff T. C., Knudsen H. K., p. S44-52.
- From research to the real world: buprenorphine in the decade of the Clinical Trials Network, Ling W., Jacobs P., Hillhouse M., Hasson A., Thomas C., Freese T., et al., p. S53-60.
- Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network, Stitzer M. L., Petry N. M., Peirce J., p. S61-69.
- Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study, Wu L. T., Pan J. J., Blazer D. G., Tai B., Stitzer M. L., Woody G. E., p. S70-79.
- Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network, Potter J. S., Chakrabarti A., Domier C. P., Hillhouse M. P., Weiss R. D., Ling W., p. S80-86.
- Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors, Campbell B. K., Tillotson C. J., Choi D., Bryant K., Dicenzo J., Provost S. E., et al., p. S87-96.
- Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?, Nunes E. V., Ball S., Booth R., Brigham G., Calsyn D. A., Carroll K., et al., p. S97-112.
- Equivalence of family functioning and externalizing behaviors in adolescent substance users of different race/ethnicity, Feaster D. J., Robbins M. S., Henderson C., Horigian V., Puccinelli M. J., Burlew A. K., et al., p. S113-124.